Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Transplantation
Volume 2013, Article ID 765230, 4 pages
http://dx.doi.org/10.1155/2013/765230
Case Report

Treatment of Recurrent Posttransplant Lymphoproliferative Disorder of the Central Nervous System with High-Dose Methotrexate

1Division of Hematology-Oncology, Department of Pediatrics, Lucile Salter Packard Children’s Hospital, Suite 300, 1000 Welch Road, Palo Alto, CA 94304, USA
2Division of Gastroenterology, Department of Pediatrics, Lucile Salter Packard Children’s Hospital, Palo Alto, CA 94304, USA

Received 12 June 2013; Accepted 30 June 2013

Academic Editors: D. Capone, J. Jazbec, and M. Klinger

Copyright © 2013 Clare J. Twist and Ricardo O. Castillo. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. M. Moser, P. C. Adamson, A. J. Gillespie, D. G. Poplack, and F. M. Balis, “Intraventricular concentration times time (C x T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma,” Cancer, vol. 85, no. 2, pp. 511–516, 1999. View at Google Scholar
  2. S. Gottschalk, C. M. Rooney, and H. E. Heslop, “Post-transplant lymphoproliferative disorders,” Annual Review of Medicine, vol. 56, pp. 29–44, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. M. C. Fernández, D. Bes, M. De Dávila et al., “Post-transplant lymphoproliferative disorder after pediatric liver transplantation: characteristics and outcome,” Pediatric Transplantation, vol. 13, no. 3, pp. 307–310, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. R. D. Holmes and R. J. Soko, “Epstein-Barr virus and post-transplant lymphoproliferative disease,” Pediatric Transplantation, vol. 6, no. 6, pp. 456–464, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. J. F. Buell, T. G. Gross, M. J. Hanaway et al., “Posttransplant lymphoproliferative disorder: significance of central nervous system involvement,” Transplantation Proceedings, vol. 37, no. 2, pp. 954–955, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Maecker, T. Jack, M. Zimmermann et al., “CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation,” Journal of Clinical Oncology, vol. 25, no. 31, pp. 4902–4908, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. Q.-S. Xu, S. Ye, Y.-Q. Zhou, J.-F. Sheng, K. Ye, and S.-S. Zheng, “Posttransplantation lymphoproliferative disorder involving the central nervous system in liver transplant recipients,” Hepatobiliary and Pancreatic Diseases International, vol. 7, no. 5, pp. 551–554, 2008. View at Google Scholar · View at Scopus
  8. A. Z. Traum, N. M. Rodig, M. E. Pilichowska, and M. J. G. Somers, “Central nervous system lymphoproliferative disorder in pediatric kidney transplant recipients,” Pediatric Transplantation, vol. 10, no. 4, pp. 505–512, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. L. B. Nabors, C. A. Palmer, B. A. Julian, A. M. Przekwas, and C. E. Kew, “Isolated central nervous system posttransplant lymphoproliferative disorder treated with high-dose intravenous methotrexate,” American Journal of Transplantation, vol. 9, no. 5, pp. 1243–1248, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. M. M. Taj, B. Messahel, J. Mycroft et al., “Efficacy and tolerability of high-dose methotrexate in central nervous system positive or relapsed lymphoproliferative disease following liver transplant in children,” British Journal of Haematology, vol. 140, no. 2, pp. 191–196, 2008. View at Publisher · View at Google Scholar · View at Scopus